{{medical}}
{{Request translation|time=2012-06-11T13:12:47+00:00}}
{{drugbox
| verifiedrevid=459442662
| drug_name=Venlafaxine
| IUPAC_name=(''RS'')-1-[2-dimethylamino-1-(4-methoxyphenyl)-ethyl]cyclohexanol
| image=Venlafaxine structure.svg
| imagename=1 : 1 mixture (racemate)
| width=175
| image2=Venlafaxine3Dan2.gif
| width2=200

<!-- Identifiers -->
| CASNo_Ref={{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII=GRZ5RCB1QG
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL=637
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey=PNVNVHUZROJLTJ-UHFFFAOYSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number=93413-69-5
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID=5454
| ATC_prefix=N06
| ATC_suffix=AX16
| ATC_supplemental =
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI=9943
| PubChem=5656
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank=DB00285

<!-- Chemical data -->
| smiles=OC2(C(c1ccc(OC)cc1)CN(C)C)CCCCC2
| C=17 |H=27 |N=1 |O=2
| molecular_weight=277.402 g/mol

<!-- Pharmacokinetic data -->
| bioavailability=42±15%<ref name=TGA>{{cite web |title=APO-VENLAFAXINE XR CAPSULES |work=TGA eBusiness Services |publisher=Apotex Pty Ltd |place=Macquarie Park, NSW |date=13 April 2012 |accessdate=6 November 2013 |url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-01095-3 |format=PDF}}</ref>

| protein_bound=27±2% (parent compound), 30±12% (active metabolite, [[desvenlafaxine|desvenlafaxine]])<ref name=DM>{{cite web |title=VENLAFAXINE (venlafaxine hydrochloride) tablet [Aurobindo Pharma Limited] |work=DailyMed |publisher=Aurobindo Pharma Limited |date=February 2013 |accessdate=6 November 2013 |url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b23637e5-d37f-41b5-ba76-fc053e903bc2}}</ref>
| metabolism=[[Hepatic|Hepatic]] (~50% of the parent compound is metabolised on first pass through the liver)<ref name=TGA/><ref name=DM/>
| elimination_half-life=5±2 hours (parent compound for immediate release preparations), 15±6 hours (parent compound for extended release preparations), 11±2 hours (active metabolite)<ref name=TGA/><ref name=DM/>

| excretion=[[Renal|Renal]] (87%; 5% as unchanged drug; 29% as [[desvenlafaxine|desvenlafaxine]] and 53% as other metabolites)<ref name=TGA/><ref name =DM/>

<!-- Clinical data -->

| tradename=Efexor, Effexor, Trevilor
| DailyMedID=b23637e5-d37f-41b5-ba76-fc053e903bc2
| Drugs.com={{drugs.com|monograph|venlafaxine}}
| pregnancy_AU=B2
| pregnancy_US=C

| legal_CA=Rx-only
| legal_US=Rx-only
| legal_UK=POM
| legal_AU=S4
| routes_of_administration=口服
}}


'''文拉法辛''' （英语：'''Venlafaxine'''，[[商品名|商品名]]: '''怡诺斯'''或'''博乐欣）'''是一种[[5-羟色胺和去甲肾上腺素再摄取抑制剂|5-羟色胺和去甲肾上腺素再摄取抑制剂]]（SNRIs）类的[[抗抑郁药|抗抑郁药]]。<ref name="pmid3790168">{{cite journal | author = Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, Sigg EB | title = Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative | journal = Biochemical Pharmacology | volume = 35 | issue = 24 | pages = 4493–7 | pmid = 3790168 | doi = 10.1016/0006-2952(86)90769-0| url = http://linkinghub.elsevier.com/retrieve/pii/0006-2952(86)90769-0|date=December 1986}}</ref><ref name="pmid1976813">{{cite journal | author = Yardley JP, Husbands GE, Stack G, ''et al.'' | title = 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity | journal = Journal of Medicinal Chemistry | volume = 33 | issue = 10 | pages = 2899–905 | pmid = 1976813 | doi = 10.1021/jm00172a035| url = |date=October 1990}}</ref><ref name="pmid11750180">{{cite journal | author = Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, ''et al.'' | title = Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors | journal = Neuropsychopharmacology | volume = 25 | issue = 6 | pages = 871–80 | pmid = 11750180 |  doi = 10.1016/S0893-133X(01)00298-6|date=December 2001}}</ref>该药首先由[[惠氏|惠氏]]于1993年研发，现在由[[辉瑞|辉瑞]]负责市场销售。该药被批准用于治疗[[重性抑郁障碍|重性抑郁障碍]]（MDD）、[[广泛性焦虑症|广泛性焦虑症]]（GAD）以及伴随焦虑的抑郁症。文拉法辛在2007年是美国零售市场上最常用的抗抑郁药第6名。<ref>The number of prescriptions was calculated as the total of prescriptions for the corresponding generic and brand-name drugs using data from the charts for generic and brand-name drugs. {{cite web | title = Top 200 generic drugs by units in 2007. | work = Drug Topics, Feb 18, 2008 | url = http://drugtopics.modernmedicine.com/drugtopics/Top200Drugs/ArticleStandard/article/detail/491194 | accessdate = 2008-10-23 | deadurl = yes | archiveurl = https://web.archive.org/web/20090718184023/http://drugtopics.modernmedicine.com/drugtopics/Top200Drugs/ArticleStandard/article/detail/491194 | archivedate = 2009年7月18日 | df =  }} {{cite web | title = Top 200 brand drugs by units in 2007. | work = Drug Topics, Feb 18, 2008 | url = http://drugtopics.modernmedicine.com/drugtopics/PharmacyFactsAndFigures/ArticleStandard/article/detail/491210 | accessdate = 2008-10-23 | deadurl = yes | archiveurl = https://web.archive.org/web/20090629042030/http://drugtopics.modernmedicine.com/drugtopics/PharmacyFactsAndFigures/ArticleStandard/article/detail/491210 | archivedate = 2009-06-29 }}</ref>

==医疗用途==
===抑郁症===
===焦虑症===
===更年期===

==不良反应==
文拉法辛口服片可能引起嗜睡。 它还可能影响做出决策，清晰思考或快速反应的能力。 服用文拉法辛期间不宜驾驶，操作重型机械，或做一些要求保持高度警觉的事情，除非服用者确知能够正常运作。 

文拉法辛也可能引起其他副作用，比如多梦和睡眠习惯改变，影响性欲，食欲。引起便秘，恶心呕吐，口干，疲劳，焦虑，晕眩，颤抖，盗汗，心率提高等。

严重的副作用包括： 产生自杀念头和尝试自杀，过激行为，愤怒焦躁不安。有可能会加剧忧郁和焦虑。也有可能导致血压升高而头痛和胸痛。

==适应症==

== 社会与文化 ==
文拉法辛最初在世界大部分地区以“Effexor”的商品名销售。现在它在全球以许多商品名销售：

Adoxa，Alfaxin，Alventa，Alventa，Amfax，Anapresin，Ansifix，Arafaxina，Argofan，Arvifax，Axone，Axyven，Blossom， Calmdown，Conervin，Convalemin，Dalium，Defaxine，Depant，Depefex，Depressa，Depretaxer，Deprevix，Deprexor，Deprixol，Depurol，Desinax，Dislaven，Dobupal，Easyfor，Ectien，Eduxon，Efaxin，Efaxine，Efectin，Efegen，Efetrin，Efevelon， Efexiva，Efexor，Effegad，Effexine，Effexor，Elafax，Elify，Enlafax，Falven，Faxigen，Faxine，Faxiprol，Faxiven，Faxolet，Flaxen，Fobiless，Foraven，Ganavax，Genexin，Idixor，Idoxen，Illovex，Ivrix，Ivryx，Ixilania， Jarvis，Lafactin，Lafaxin，Lanvexin，Levest，Mazda，Melocin，Memomax，Mezine，Mollome，Nefexyl，Nervix，Norafexine，Norezol，Norezor，Norpilen，Novidat，Noviser，Odiven，Olwexya，Oriven，Paxifar，Politid，Pracet，Pramina， Prefaxine，Quilarex，Rafax，Senexon，Sentidol，Sentosa，Serosmin，Seroxine，Sesar en，Subelan，Sunveniz，Sunvex，Symfaxin，Tedema，Tifaxin，Tonpular，Trevilor，Tudor，Valosine，Vandral，Velaf，Velafax，Velahibin，Velaxin，Velept，Velpine，Ven-Fax，Venax，Venaxibene，Venaxol，Venaxx，Vencontrol， Vendep，Venegis，Venex，Venexor，Venfalex，Venfax，Venfaxime，Venforspine，Veniba，Veniz，Venjoy，Venla，Venlabacher，Venlabax，Venlabrain，Venlaburg，Venladex，Venladoz，Venlaf，Venlafab，Venlafaxin，Venlafaxina，Venlafaxine，Venlafaxinum，Venlafectin， Venlagamma，Venlalic，Venlamax，Venlamylan，Venlaneo，Venlanofi，Venlapine，Venlasand，Venlatif，Venlatrin，Venlax，Venlaxin，Venlaxine，Venlaxor，Venlectine，Venlexor，Venlifax，Venlift，Venlix，Venlobax，Venlofex，Venlor，Venoxor，Venozap，Venxin， Venxor，Vexamode，Vfax，Viepax，Voxafen，Xadevil，Xapnev，Zacalen，Zanfexa，Zaredrop，Zarelis，Zarelix和Zenexor等等。<ref>{{Cite web|title=Venlafaxine|url=https://www.drugs.com/international/venlafaxine.html|work=Drugs.com|accessdate=2019-03-30|language=en}}</ref>
<br />
==参考文献==
{{reflist}}

{{Antidepressants}}
{{Anxiolytics}}
{{Serotonergics}}
{{Sigmaergics}}
{{ADHD_pharmacotherapies}}
[[Category:醇|Category:醇]]
[[Category:雙環抗抑鬱藥|Category:雙環抗抑鬱藥]]
[[Category:芳香醚|Category:芳香醚]]
[[Category:血清素-去甲肾上腺素重摄取抑制剂|Category:血清素-去甲肾上腺素重摄取抑制剂]]
[[Category:Σ激动剂|Category:Σ激动剂]]